Thermo Fisher Scientific
Venture capital · Waltham, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio1 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Nuvation Bio
20Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| ImmunGene | Biotech | Active | — | — |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Arctus Biosciences | Biotech | Public | — | — |
| Singular Genomics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#108
Portfolio exits#69
Raises, 12 months#88
Co-investors#105
Co-investors
- Andreessen HorowitzVenture capital2 shared
- Asahi Kasei Corporate Venture CapitalVenture capital1 shared
- Blackstone Life SciencesVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Deerfield Capital ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- General CatalystVenture capital1 shared
- GVVenture capital1 shared
- IlluminaVenture capital1 shared
- Mayo ClinicVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.